CrushSCI.com
118.4Average days
110.5Median days
5Fastest days
205Longest days
1482025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

88 days

Retrospective (Q)SAR analysis of genotoxicity data from European pharmaceutical scientific advice and authorization procedures and performance improvements using structural alert and chemical subspace analyses, reliability filtering, and expert review

Authors
Ajouan Mazoudji; Daniela Digles; Manfred Schuster; Alan Sanh; Fabien Lavergne; Martin Paparella; Gerhard F. Ecker; Martin WalterShow moreShow less
Affiliations
Austrian Agency for Health and Food Safety GmbH, Austrian Medicines & Medical Devices Agency (AGES-MEA), Traisengasse 5, Vienna, 1200, Austria; University of Vienna, Department of Pharmaceutical Sciences, Josef-Holaubek-Platz 2, Vienna, 1090, Austria; French National Agency for Medicines and Health Products Safety (ANSM), 43/147, boulevard Anatole France, 93285, Saint-Denis Cedex, France; Medical University of Innsbruck, Institute of Medical Biochemistry, Innrain 80-82, Innsbruck, A-6020, AustriaShow moreShow less
Source PDF DOI Publisher page
119 days

Mutagenicity studies on migrants from food-contact silicone products based on Ames test and chemical analysis

Authors
Peixue Guo; Zhaoxi Liu; Jin Rong; Xueting Feng; Xiaojie Fan; Di FengShow moreShow less
Affiliations
Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, 100048, ChinaShow moreShow less
Source PDF DOI Publisher page
64 days

Establishment of expanded botanical thresholds of toxicological concern: Enrichment of botanical PoD databases and new thresholds

Authors
Gyeyoung Choi; Eunsu Kim; Jieun Lee; Seo Young Shin; YoungMi Kim; Boyeon Kim; Yeyoung Kim; Haneul Kim; Seonmin Park; Eunseo Seo; Seungjin Bae; Kyung-Min LimShow moreShow less
Affiliations
College of Pharmacy, Ewha Womans University, Seoul, South Korea; Graduate Program in Regulatory Science Convergence, Ewha Womans University, Seoul, South KoreaShow moreShow less
Source PDF DOI Publisher page
5 days

New approach methodologies in pharmaceutical development: Survey insights on adoption, infrastructure, and the path to broader implementation

Authors
Jessica C. Graham; Brandy Morenko; Damodaran Annamalai; Fatima Arjmand; Monika Burns; Danielle Elbirt; Brianna N. Gaskill; Moran Grossman; Dawn S.Y. Lin; Kathy Orsted; Rosemary Santos; Alanna Sedgwick; Margit SpatzeneggerShow moreShow less
Affiliations
Eli Lilly and Company, Indianapolis, IN, USA; Pfizer Inc., Groton, CT, USA; Biogen Inc, Cambridge, MA, USA; Gilead Sciences Inc., Foster City, CA, USA; Novartis Biomedical Research, Cambridge, MA, USA; MilliporeSigma, Burlington, MA, USA; Teva Pharmaceutical Industries Ltd., Netanya, Israel; Merck & Co., Inc., Rahway, NJ, USA; Vividion Therapeutics, San Diego, CA, USA; CSL Behring GmbH, Vienna, AustriaShow moreShow less
Source PDF DOI Publisher page
69 days

Suitability of the ICH S1B(R1) weight-of-evidence framework to evaluate glucagon-like protein-1 receptor agonist (GLP-1RA) carcinogenicity risk

Authors
Katherine A. Roach; Manoochehr Khazaee; Isaac Mohar; Denali Boon; Brigitte Cronin; Alex G. GauthierShow moreShow less
Affiliations
Gradient, 103 East Water Street, Charlottesville, VA, 22902, USA; Gradient, 801 5th Ave., Suite 2200, Seattle, WA, 98104, USA; Gradient, One Beacon Street, 17th Floor, Boston, MA, 02108, USA; Novartis Pharma AG, 250 Massachusetts Avenue, Cambridge, MA, 02139, USAShow moreShow less
Source PDF DOI Publisher page
102 days

Multi-pathway human exposure to NORM from facial foundation powders available on the Turkish market: Assessing lifetime cancer risks for adult users

Authors
Şeref Turhan; Celalettin Enes Demirci; Aslı KurnazShow moreShow less
Affiliations
Department of Physics, Faculty of Science, Kastamonu University, Kastamonu, 37150, Turkey; Department of Physics, Graduate Education Institute, Kastamonu University, Kastamonu, 37150, TurkeyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does REGULATORY TOXICOLOGY AND PHARMACOLOGY take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for REGULATORY TOXICOLOGY AND PHARMACOLOGY. The fastest paper went from submission to acceptance in 5 days (New approach methodologies in pharmaceutical development: Survey insights on adoption, infrastructure, and the path to broader implementation, received 2026-09-24, accepted 2026-09-29); the slowest took 205 days. The average is 118.4 days and the median is 110.5 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.